相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Proteomic characterization of human multiple myeloma bone marrow extracellular matrix
S. V. Glavey et al.
LEUKEMIA (2017)
Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy
David Dingli et al.
MAYO CLINIC PROCEEDINGS (2017)
The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma
Yuji Mishima et al.
CELL REPORTS (2017)
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group
J. Laubach et al.
LEUKEMIA (2016)
Genetic interrogation of circulating multiple myeloma cells at single-cell resolution
Jens G. Lohr et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Predicting the response of multiple myeloma to the proteasome inhibitor Bortezomib by evaluation of the unfolded protein response
N. Nikesitch et al.
BLOOD CANCER JOURNAL (2016)
De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas
Sihem Mebarki et al.
ONCOTARGET (2016)
Microenvironment drug resistance in multiple myeloma: emerging new players
Lucia Di Marzo et al.
ONCOTARGET (2016)
Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer
Suniti Misra et al.
FRONTIERS IN IMMUNOLOGY (2015)
Overcoming bortezomib resistance in multiple myeloma
Megan Y. Murray et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
Understanding Biology to Tackle the Disease: Multiple Myeloma From Bench to Bedside, and Back
Giada Bianchi et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
Jens G. Lohr et al.
CANCER CELL (2014)
The Nedd8-Activating Enzyme Inhibitor MLN4924 Thwarts Microenvironment-Driven NF-κB Activation and Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells
J. Claire Godbersen et al.
CLINICAL CANCER RESEARCH (2014)
Matricryptins and matrikines: biologically active fragments of the extracellular matrix
Sylvie Ricard-Blum et al.
EXPERIMENTAL DERMATOLOGY (2014)
Covalent Modification of the NF-kappa B Essential Modulator (NEMO) by a Chemical Compound Can Regulate Its Ubiquitin Binding Properties in Vitro
Christopher Hooper et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Global cellular response to chemotherapy-induced apoptosis
Arun P. Wiita et al.
ELIFE (2013)
Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells
Jaehyup Kim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Matthew S. Hayden et al.
GENES & DEVELOPMENT (2012)
Ubiquitination in signaling to and activation of IKK
Zhijian J. Chen
IMMUNOLOGICAL REVIEWS (2012)
Initial genome sequencing and analysis of multiple myeloma
Michael A. Chapman et al.
NATURE (2011)
Inflammation meets cancer, with NF-κB as the matchmaker
Yinon Ben-Neriah et al.
NATURE IMMUNOLOGY (2011)
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Peter Walter et al.
SCIENCE (2011)
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB-dependent lymphoma
Michael A. Milhollen et al.
BLOOD (2010)
Ubiquitylation and proteasomal degradation of the p21Cip1, p27Kip1 and p57Kip2 CDK inhibitors
Zhimin Lu et al.
CELL CYCLE (2010)
Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells
Stephanie Markovina et al.
MOLECULAR CANCER (2010)
Distinct Genetic Alterations in Colorectal Cancer
Hassan Ashktorab et al.
PLOS ONE (2010)
Oncogenic Activation of NF-kappa B
Louis M. Staudt
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
A critical role for the NFkB pathway in multiple myeloma
Yulia N. Demchenko et al.
ONCOTARGET (2010)
A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer
Christina Yau et al.
BREAST CANCER RESEARCH (2010)
Bortezomib induces canonical nuclear factor-κB activation in multiple myeloma cells
Teru Hideshima et al.
BLOOD (2009)
Bone marrow microenvironment and the identification of new targets for myeloma therapy
K. Podar et al.
LEUKEMIA (2009)
Dysregulation of unfolded protein response partially underlies proapoptotic activity of bortezomib in multiple myeloma cells
Hongjuan Dong et al.
LEUKEMIA & LYMPHOMA (2009)
Molecular basis of bortezomib resistance:: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein
Ruud Oerlemans et al.
BLOOD (2008)
Bortezomib-resistant nuclear Factor-κB activity in multiple myeloma cells
Stephanie Markovina et al.
MOLECULAR CANCER RESEARCH (2008)
Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma
Jonathan J. Keats et al.
CANCER CELL (2007)
Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma
Christina M. Annunziata et al.
CANCER CELL (2007)
Hyaluronan fragments act as an endogenous danger signal by engaging TLR2
Kara A. Scheibner et al.
JOURNAL OF IMMUNOLOGY (2006)
Matrikines in the regulation of extracellular matrix degradation
F Maquart et al.
BIOCHIMIE (2005)
Expression and purification of functionally active hyaluronan-binding domains from human cartilage link protein, aggrecan and versican - Formation of ternary complexes with defined hyaluronan oligosaccharides
NT Seyfried et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Nuclear factor-κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis
AC Bharti et al.
BLOOD (2004)
An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity - Implication in tumor invasion
FX Maquart et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
Regulation of constitutive p50/c-rel activity via proteasome inhibitor-resistant IκBα degradation in B cells
S O'Connor et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
A mechanistic insight into a proteasome-independent constitutive inhibitor κBα (IκBα) degradation and nuclear factor κB (NF-κB) activation pathway in WEHI-231 B-cells
SD Shumway et al.
BIOCHEMICAL JOURNAL (2004)
The link module from ovulation- and inflammation-associated protein TSG-6 changes conformation on hyaluronan binding
CD Blundell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
NF-κB as a therapeutic target in multiple myeloma
T Hideshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
